Sharon Shacham

2020

In 2020, Sharon Shacham earned a total compensation of $3.7M as President and Chief Scientific Officer at Karyopharm Therapeutics, a 22% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$224,595
Option Awards$1,920,899
Salary$483,624
Stock Awards$1,029,886
Other$11,880
Total$3,670,884

Shacham received $1.9M in option awards, accounting for 52% of the total pay in 2020.

Shacham also received $224.6K in non-equity incentive plan, $483.6K in salary, $1M in stock awards and $11.9K in other compensation.

Rankings

In 2020, Sharon Shacham's compensation ranked 3,155th out of 13,090 executives tracked by ExecPay. In other words, Shacham earned more than 75.9% of executives.

ClassificationRankingPercentile
All
3,155
out of 13,090
76th
Division
Manufacturing
1,230
out of 5,618
78th
Major group
Chemicals And Allied Products
467
out of 2,251
79th
Industry group
Drugs
405
out of 1,951
79th
Industry
Pharmaceutical Preparations
303
out of 1,456
79th
Source: SEC filing on April 7, 2021.

Shacham's colleagues

We found two more compensation records of executives who worked with Sharon Shacham at Karyopharm Therapeutics in 2020.

2020

Michael Kauffman

Karyopharm Therapeutics

Chief Executive Officer

2020

Michael Mason

Karyopharm Therapeutics

Chief Financial Officer

News

In-depth

You may also like